Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Ribalta

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Atherosclerosis|April 7, 2009
The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial studyFernando Cardona, Montserrat Guardiola, María Isabel Queipo-Ortuño, et al.
Atherosclerosis|August 7, 2010
The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study)Montse Guardiola, Josep Ribalta, Diego Gómez-Coronado, et al.
Molecular and Cellular Probes|March 12, 2003
Two novel single nucleotide polymorphisms in the promoter of the cellular retinoic acid binding protein II gene (CRABP-II)Juliana Salazar, Raimon Ferré, Joan-Carles Vallvé, et al.
The Journal of Rheumatology|July 18, 2008
Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritisJoan-Carles Vallvé, Silvia Paredes, Josefa Girona, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 2, 2007
Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patientsJosefa Girona, Josep M Manzanares, Francesc Marimón, et al.
Clinical Chemistry|August 5, 2006
Protease inhibitor-associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T->C gene variationMontse Guardiola, Raimon Ferré, Juliana Salazar, et al.
Clinical Science (London, England : 1979)|September 11, 2016
APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levelsIris Oliva, Montse Guardiola, Joan-Carles Vallvé, et al.
AIDS Research and Human Retroviruses|June 24, 2015
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent mannerMontse Guardiola, Patricia Echeverria, Marta González, et al.
Plos One|August 23, 2012
Two variants in the fibulin2 gene are associated with lower systolic blood pressure and decreased risk of hypertensionJoan-Carles Vallvé, Noemí Serra, Guillermo Zalba, et al.
Diabetes Research and Clinical Practice|June 10, 2023
NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: The Di@bet.es studyEnrique Ozcariz, Montse Guardiola, Núria Amigó, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Atherosclerosis|April 7, 2009
The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial studyFernando Cardona, Montserrat Guardiola, María Isabel Queipo-Ortuño, et al.
Atherosclerosis|August 7, 2010
The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study)Montse Guardiola, Josep Ribalta, Diego Gómez-Coronado, et al.
Molecular and Cellular Probes|March 12, 2003
Two novel single nucleotide polymorphisms in the promoter of the cellular retinoic acid binding protein II gene (CRABP-II)Juliana Salazar, Raimon Ferré, Joan-Carles Vallvé, et al.
The Journal of Rheumatology|July 18, 2008
Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritisJoan-Carles Vallvé, Silvia Paredes, Josefa Girona, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 2, 2007
Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patientsJosefa Girona, Josep M Manzanares, Francesc Marimón, et al.
Clinical Chemistry|August 5, 2006
Protease inhibitor-associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T->C gene variationMontse Guardiola, Raimon Ferré, Juliana Salazar, et al.
Clinical Science (London, England : 1979)|September 11, 2016
APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levelsIris Oliva, Montse Guardiola, Joan-Carles Vallvé, et al.
AIDS Research and Human Retroviruses|June 24, 2015
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent mannerMontse Guardiola, Patricia Echeverria, Marta González, et al.
Plos One|August 23, 2012
Two variants in the fibulin2 gene are associated with lower systolic blood pressure and decreased risk of hypertensionJoan-Carles Vallvé, Noemí Serra, Guillermo Zalba, et al.
Diabetes Research and Clinical Practice|June 10, 2023
NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: The Di@bet.es studyEnrique Ozcariz, Montse Guardiola, Núria Amigó, et al.
Pageof 10